Dermapharm Holding SE

    Jurisdiction
    Germany
    LEI
    5299009F0KNZINQQQK37
    ISIN
    DE000A2GS5D8 (DMP.DE)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - Specialty & Generic

    Scores

    InsiderPie Expert Score
    trending_flat 51 / 100
    Even with peer group:
    52 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    8 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    4 / 7

    Profile

    Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €1.18B
    Gross margin
    65.7%
    EBIT
    €218.27M
    EBIT margin
    18.5%
    Net income
    €107.20M
    Net margin
    9.1%

    Statement period: - (published )

    Dividends

    Last dividend amount
    €0.90
    Ex date
    Payment date

    Analyst ratings

    3 analysts rated this company in the past 90 days. The average target price is €39.67, this is a change of +21.3% compared to the current price.

    Add to watchlist

    Notifications